TheraRadar
Clinical-Stage Companies / Il-Yang Pharm.

Il-Yang Pharm.

Pre-Approval PRO BETA
28
Total Trials
12
Phase 3
3
Phase 2
7
Recruiting
253
Score

Pipeline by Phase

Phase 3
12
Phase 2
3
Phase 1
13

Therapeutic Focus

Healthy Pharmacokinetics Drug Interaction Potentiation Peptic Ulcer Chronic Myeloid Leukemia, Chronic Phase

Clinical Trials (28)

NCT06284876 Phase 3 RECRUITING

Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic Ulcer

Started: 7/23/2024

NCT03459534 Phase 3 RECRUITING

A Phase 3 Study for the Efficacy and Safety of Radotinib in CP-CML Patients With Failure or Intolerance to Previous TKIs

Started: 6/25/2018

NCT04381689 Phase 3 ACTIVE NOT RECRUITING

Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactived Split Influenza Vaccine in Healthy Korea Infants

Started: 10/23/2024

NCT03722420 Phase 3 ACTIVE NOT RECRUITING

Randomized Evaluation of Radotinib Versus Imatinib in Phase III Study for Efficacy With Chinese Patients (RERISE China)

Started: 12/28/2018

NCT02677493 Phase 3 COMPLETED

Study to Evaluate the Immunogenicity and Safety of 'IL-YANG Quadrivalent Influenza Vaccine Inj.'

Started: 10/1/2015

NCT03444883 Phase 3 COMPLETED

Phase III Study to Evaluate Safety and Efficacy of Ilaprazole in Patients With NERD

Started: 10/31/2018

NCT02263131 Phase 3 COMPLETED

Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactivated Split Influenza Vaccine in Healthy Korea Children

Started: 10/1/2013

NCT03445468 Phase 3 COMPLETED

Immunogenicity and Safety for 'IL-YANG Quadrivalent Influenza Vaccine' in Healthy Korean Children and Adolescents

Started: 9/20/2017

NCT01511289 Phase 3 COMPLETED

Radotinib Versus Imatinib in Newly Diagnosed Philadelphia Chromosome and Chronic Myeloid Leukemia Chronic Phase Patients

Started: 8/1/2011

NCT02154308 Phase 3 COMPLETED

Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactivated Split Influenza Vaccine in Healthy Korea Adults

Started: 11/1/2012

NCT02084420 Phase 3 COMPLETED

Efficacy/Safety Study as H. Pylori Eradication of Triple Therapy for 7 Days Treatment

Started: 12/1/2012

NCT01509261 Phase 3 COMPLETED

Efficacy Study of Ilaprazole to Treat Erosive Esophgitis

Started: 7/1/2010

NCT04691661 Phase 2 RECRUITING

Safety, Tolerability, Pharmacokinetics and Efficacy Study of Radotinib in Parkinson's Disease

Started: 9/9/2021

NCT07433556 Phase 1 RECRUITING

Safety, Tolerability, Pharmacokinetic and Pharmacodynamic of IY-828026 in Healthy Volunteers

Started: 3/23/2026

NCT07322991 Phase 1 COMPLETED

Study to Evaluate the Drug-drug Interaction Between IY001 and IY002 in Healthy Adult Male Subjects.

Started: 10/14/2025

NCT06461078 Phase 1 COMPLETED

Clinical Trial to Investigate the Effects of Food on the Pharmacokinetics and Safety of Orally Administered Radotinib

Started: 7/22/2024

NCT06725992 Phase 1 COMPLETED

Study to Evaluate Pharmacokinetic and Pharmacodynamic Drug Interactions and Safety of IY-NS250 and IY-NT-SR

Started: 1/30/2024

NCT06471868 Phase 1 ACTIVE NOT RECRUITING

Study to Evaluate Pharmacokinetic and Pharmacodynamic Drug Interactions and Safety of IY-HCR21 and IY-MIC

Started: 6/10/2024

NCT05509543 Phase 1 COMPLETED

Study to Evaluate the Safety and the Pharmacokinetics of IY-NT-T

Started: 8/24/2022

NCT05237297 Phase 1 COMPLETED

Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Naproxen, Aceclofenac, Celecoxib and Ilaprazole

Started: 2/17/2022

NCT05558150 Phase 1 COMPLETED

Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Ilaprazole and Aceclofenac

Started: 11/10/2022

NCT02480998 Phase 1 COMPLETED

Study to Evaluate the Safety and Immunogenicity of 'IL-YANG Flu Vaccine Quadrivalent Inj' in Healthy Korean Adults

Started: 2/1/2015

NCT01602952 Phase 1 COMPLETED

Philadelphia Chromosome Positive CML Patients Without Optimal Response or Tolerance to Bcr-Abl TKI

Started: 7/1/2008

NCT02998437 Phase 1 COMPLETED

Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Clarithromycin, Amoxicillin and Ilaprazole

Started: 12/1/2016

NCT02330003 Phase 1 COMPLETED

Phase 1 Study to Assess the Safety of Inactivated Split Influenza Vaccine and Control Vaccine in Korean Volunteer

Started: 5/1/2013

NCT02111070 Phase 1 COMPLETED

Immunogenicity and Safety Study of Inactivated Split Influenza Vaccine' in Healthy Korean Male Subjects

Started: 9/1/2012

NCT02638584 Phase 4 COMPLETED

Effects of Ilaprazole on Ulcer Healing Rate and Prevention of Gastrointestinal Bleeding in the Patients Undergone ESD.

Started: 12/1/2015

NCT02401477 Phase 4 COMPLETED

Dual Therapy With High Doses of Ilaprazole and Amoxicillin for Helicobacter Pylori Infection

Started: 12/1/2014

Drug Candidates

IY-828026 Placebo IY-828026A IY-828026B IL-YANG FLU Vaccine Prefilled Syringe INJ. Fluarix Tetra Pre-filled Syringe IY001(Finasteride) IY002(Tamsulosin) Ilaprazole Lansoprazole
Activity Status: Active
Last Trial Started: 3/23/2026
Last Trial Ended: 12/1/2025
Trials (12 months): 2
Completed Trials: 21
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.